Braizon Therapeutics
Hongo
About Braizon Therapeutics
Braizon Therapeutics, Inc. was established with the aim of applying and implementing, within the fields of medicine and life science, innovative technology for the delivery of drugs to the brain as the outcome of collaborative research by Professor Kazunori Kataoka from the Graduate School of Engineering/Medicine, the University of Tokyo and Professor Takanori Yokota from the Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2021)
- Website: braizon.com
- Phone: +81-3-5805-3417
Industries & Categories
Biotechnology, Education, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/braizon-therapeutics-78659 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.